• Reset
Results: 17725 found
LOCATIONS
Asia, Southern
LOCATIONS
Afghanistan
LOCATIONS
Europe
LOCATIONS
Africa, Northern
LOCATIONS
Oceania
LOCATIONS
Africa, Southern
LOCATIONS
Angola
LOCATIONS
America, Central
LOCATIONS
Antigua and Barbuda
LOCATIONS
America, Southern
LOCATIONS
Argentina
LOCATIONS
Australia
LOCATIONS
Austria
LOCATIONS
Bahamas
LOCATIONS
Asia, Western
LOCATIONS
Bangladesh
LOCATIONS
Barbados
LOCATIONS
Belarus
LOCATIONS
Belgium
LOCATIONS
Belize

Country Portfolio of Malaria Research & Investments

LOCATIONS
Africa, Western
LOCATIONS
Benin
LOCATIONS
America, Northern
LOCATIONS
Bermuda
LOCATIONS
Bhutan
LOCATIONS
Bolivia
LOCATIONS
Bosnia and Herzegovina
LOCATIONS
Botswana
LOCATIONS
Brazil
LOCATIONS
Asia, Southeastern
LOCATIONS
Burkina Faso
LOCATIONS
Africa, Eastern
LOCATIONS
Burundi
LOCATIONS
Cabo Verde

Country Portfolio of Malaria Research & Investments

LOCATIONS
Cambodia
LOCATIONS
Africa, Central
LOCATIONS
Cameroon
LOCATIONS
Canada
LOCATIONS
Central African Republic
LOCATIONS
Chad
LOCATIONS
Chile
LOCATIONS
Asia, Eastern
LOCATIONS
China

Country Portfolio of Malaria Research & Investments

LOCATIONS
Colombia
LOCATIONS
Comoros
LOCATIONS
Congo
LOCATIONS
Dem. Rep. of Congo
LOCATIONS
Costa Rica
LOCATIONS
Côte d'Ivoire
LOCATIONS
Croatia
LOCATIONS
Cuba
LOCATIONS
Czechia
LOCATIONS
Denmark
LOCATIONS
Djibouti
LOCATIONS
Dominica
LOCATIONS
Dominican Republic
LOCATIONS
Ecuador
LOCATIONS
Egypt
LOCATIONS
El Salvador

Country Portfolio of Malaria Research & Investments

LOCATIONS
Equatorial Guinea
LOCATIONS
Eritrea
LOCATIONS
Estonia
LOCATIONS
Ethiopia
LOCATIONS
Finland
LOCATIONS
France
LOCATIONS
French Guiana
LOCATIONS
Gabon
LOCATIONS
The Gambia
LOCATIONS
Germany
LOCATIONS
Ghana

Country Portfolio of Malaria Research & Investments

LOCATIONS
Greece

Country Portfolio of Malaria Research & Investments

LOCATIONS
Grenada
LOCATIONS
Guam
LOCATIONS
Guatemala
LOCATIONS
Guinea
LOCATIONS
Guinea-Bissau
LOCATIONS
Guyana
LOCATIONS
Haiti
LOCATIONS
Honduras
LOCATIONS
Hong Kong
LOCATIONS
Hungary
LOCATIONS
India
LOCATIONS
Indonesia
LOCATIONS
Iran
LOCATIONS
Ireland
LOCATIONS
Israel
LOCATIONS
Italy
LOCATIONS
Jamaica
LOCATIONS
Japan
LOCATIONS
Jordan
LOCATIONS
Asia, Central
LOCATIONS
Kazakhstan
LOCATIONS
Kenya

Country Portfolio of Malaria Research & Investments

LOCATIONS
North Korea
LOCATIONS
South Korea
LOCATIONS
Lao PDR
LOCATIONS
Latvia
LOCATIONS
Lebanon
LOCATIONS
Lesotho
LOCATIONS
Liberia

Country Portfolio of Malaria Research & Investments

LOCATIONS
Liechtenstein
LOCATIONS
Lithuania
LOCATIONS
Luxembourg
LOCATIONS
Madagascar
LOCATIONS
Malawi

Country Portfolio of Malaria Research & Investments

LOCATIONS
Malaysia
LOCATIONS
Mali

Country Portfolio of Malaria Research & Investments

LOCATIONS
Malta
LOCATIONS
Mauritania
LOCATIONS
Mauritius

Country Portfolio of Malaria Research & Investments

LOCATIONS
Mexico
LOCATIONS
Morocco
LOCATIONS
Mozambique

Country Portfolio of Malaria Research & Investments

LOCATIONS
Myanmar
LOCATIONS
Namibia
LOCATIONS
Nepal
LOCATIONS
The Netherlands
LOCATIONS
New Zealand
LOCATIONS
Nicaragua
LOCATIONS
Niger
LOCATIONS
Nigeria

Country Portfolio of Malaria Research & Investments

LOCATIONS
Norway
LOCATIONS
Pakistan
LOCATIONS
Panama
LOCATIONS
Papua New Guinea
LOCATIONS
Paraguay

Country Portfolio of Malaria Research & Investments

LOCATIONS
Peru

Country Portfolio of Malaria Research & Investments

LOCATIONS
Philippines
LOCATIONS
Poland
LOCATIONS
Portugal
LOCATIONS
Qatar
LOCATIONS
Réunion

Country Portfolio of Malaria Research & Investments

LOCATIONS
Romania
LOCATIONS
Russian Federation
LOCATIONS
Rwanda

Country Portfolio of Malaria Research & Investments

LOCATIONS
Saint Kitts and Nevis
LOCATIONS
Saint Lucia
LOCATIONS
Saint Vincent and the Grenadines
LOCATIONS
Sao Tome and Principe
LOCATIONS
Saudi Arabia
LOCATIONS
Senegal

Country Portfolio of Malaria Research & Investments

LOCATIONS
Sierra Leone
LOCATIONS
Singapore
LOCATIONS
Slovakia
LOCATIONS
Solomon Islands
LOCATIONS
Somalia
LOCATIONS
South Africa

Country Portfolio of Malaria Research & Investments

LOCATIONS
South Sudan
LOCATIONS
Spain
LOCATIONS
Sri Lanka

Country Portfolio of Malaria Research & Investments

LOCATIONS
Sudan
LOCATIONS
Suriname
LOCATIONS
Eswatini
LOCATIONS
Sweden
LOCATIONS
Switzerland
LOCATIONS
Syria
LOCATIONS
Tajikistan

Country Portfolio of Malaria Research & Investments

LOCATIONS
Tanzania

Country Portfolio of Malaria Research & Investments

LOCATIONS
Thailand
LOCATIONS
Togo
LOCATIONS
Trinidad and Tobago
LOCATIONS
Tunisia

Country Portfolio of Malaria Research & Investments

LOCATIONS
Türkiye
Country Portfolio of Malaria Research & Investments
LOCATIONS
Turkmenistan

Country Portfolio of Malaria Research & Investments

LOCATIONS
Uganda
LOCATIONS
United Arab Emirates
LOCATIONS
United Kingdom
LOCATIONS
United States
LOCATIONS
Uruguay
LOCATIONS
Vanuatu
LOCATIONS
Venezuela
LOCATIONS
Vietnam
LOCATIONS
Yemen
LOCATIONS
Zambia

Country Portfolio of Malaria Research & Investments

LOCATIONS
Zimbabwe
Projects: 6768 Updates: 1851 Resources: 1288 Institutions: 2619 Principal Investigators: 5071 Deep Dives: 24
Feb 2013 —
Jan 2016

$159,000

Identification of the genetic basis of primaquine resistance in malaria parasites
University of California San Diego (UCSD)
Drug Resistance | Genetics and Genomics | P. vivax
Feb 2013 —
Jan 2016

$372,000

Leveraging RC-12 for Radical Cure of Plasmodium Vivax
University of Nebraska Lincoln (UNL)
Drug-based Strategies | P. vivax | Product Development
Jan 2013 —
Aug 2018

$4.37M

Improving the radical cure of vivax malaria: A multicentre randomised comparison of short and long course primaquine regimens
University of Oxford
Drug-based Strategies | P. vivax
Sep 2011 —
Jan 2020

$2.7M

Great Ape Reservoirs of Human Malaria
University of Pennsylvania
Basic Science | Genetics and Genomics | P. vivax
Dec 2011 —
Nov 2016

$1.72M

Defining the population at risk and burden of disease of Plasmodium vivax malaria
University of Oxford
Measurement of Transmission | P. vivax
Jan 2012 —
Dec 2015

$597,000

Phenotypic Characterisation of Chloroquine Resistance in malaria parasites
Menzies School of Health Research
Drug Resistance | P. vivax
Feb 2012 —
Jan 2016

$484,000

Chimeric hybrid transmission blocking vaccine for malaria
Emory University
P. vivax | Product Development | Vaccines
Aug 2012 —
Jul 2015

$571,438

SBIR Phase II: Broad-based urine test for the diagnosis of Plasmodium falciparum and P. vivax malaria In febrile patients
Fyodor Biotechnologies
Diagnostics
Jun 2012 —
May 2017

$647,959

Transmission blocking vaccine study in Plasmodium vivax
China Medical University
P. vivax | Product Development | Vaccines
Mar 2012 —
Aug 2015

$357,000

Genetic screen for P. vivax CQR
University of South Florida
Drug Resistance | Drug-based Strategies | P. vivax | Surveillance
Jul 2012 —
Jun 2015

$489,974

Coadministration of capsid modified adenovirus for malaria vaccine development
Emory University
Enabling Technologies & Assays | P. vivax | Vaccines
Jan 2013 —
Apr 2017

$383,599

Intermittent Screening and Treatment for the control of malaria in the first year of life in Papua, Indonesia: A cluster randomized controlled trial
University of Gadjah Mada (UGM)
Drug-based Strategies | Surveillance | Vulnerable Populations
Jul 2012 —
Jun 2015

$240,000

Predictive Structure-Based Models of Malaria Resistance
Southwestern College
Basic Science | Drug Resistance | Enabling Technologies & Assays | Modeling | P. vivax
Mar 2013 —
Feb 2016

$127,000

Innate Immune Activation in Malaria
University of Massachusetts (UMass) Amherst
Basic Science | Genetics and Genomics | Immunology | P. vivax
Mar 2014 —
Feb 2018

$676,000

Evolutionary medicine in the development of antimalaria drugs
Harvard University
Basic Science | Drug Resistance | Drug-based Strategies | Enabling Technologies & Assays
Dec 2014 —
Nov 2019

$1.83M

Single Cell Genomics for Malaria Parasites
Texas Biomedical Research Institute (TBRI)
Genetics and Genomics
Aug 2010 —
Jul 2015

$2.12M

Optimising antimalarial combination therapies in an area coendemic for vivax and falciparum malaria
University of Oxford | Wellcome Sanger Institute
Drug-based Strategies | Impact of Interventions | P. vivax
Jun 2010 —
May 2016

$547,000

Malaria Research Training in South India
Penn State Milton S. Hershey Medical Center
Capacity Strengthening | Drug Resistance | Epidemiology | P. vivax | Vulnerable Populations
Oct 2003 —
Dec 2018

$1.9M

Enhancing vivax malaria research in Thailand
Pennsylvania State University (PSU)
Drug Resistance | Measurement of Transmission | P. vivax
Jan 2012 —
Jan 2014
A open label, randomized controlled trial of Artesunate Sulfadoxine- Pyrimethamine (AS-SP) vs Artesunate – Sulfadoxine-Pyrimethamine + Primaquine (AS-SP+PQ) for decreasing malaria transmission in India
National Institute of Malaria Research (NIMR), Indian Council of Medical Research (ICMR)
Drug-based Strategies | Operational Research
« First
Last »